1.
Sweiss NJ, Noth I, Mirsaeidi M, Zhang W, Naureckas ET, Hogarth DK, et al. Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. 2014 Apr. 18 [cited 2024 Jul. 18];31(1):46-54. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/2943